Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) · 2025
[Drug hypersensitivity: When systemic symptoms and pustules converge].
СтатьяКлинический случайАннотация на английскомНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Palafox-Olvera Ariadna, Puerto-Díaz Edgardo Adrian, Mellado-Ábrego Jaime, Hernández-Nieto Leticia, Castillo-Narvaéz Gloria, Moncayo-Coello Carol Vivian
Аннотация
BACKGROUND: Overlap (SCARs) severe cutaneous adverse drug reactions, are defined as cases that fulfill diagnostic criterio for at least two of these drug-associated reactions, according to scoring systems. We present a case of an overlapping SCAR.
CASE REPORT: A 53-year-old female was diagnosed with diabetes and was being treated with metformin and linagliptin, and with high blood pressure with nifedipine. Secondary to an isolated seizure, she was treated with phenytoin, 5 weeks later, she presented with erythema in the chest region accompanied by pruritus that spread to the abdomen. Treatment was initiated with antihistamines, with poor improvement, progressing to generalized erythema and fever. Upon admission, she presented with generalized polymorphic skin lesions of a maculopapular rash and bullous lesions on the forearms, as well as pustular lesions on the face. Laboratory findings: Leukocytosis with neutrophilia (67%), eosinophilia =3,880/mm3, and acute kidney injury. Biopsy: Chronic interface dermatitis, superficial perivasculitis, and eosinophilia. According to RegiSCAR scoring system with 4 points and the EuroSCAR score with 6 points, both considered probable The patient began steroid therapy with methylprednisolone at 1.5 mg/kg for 3 days, followed by reduced doses of prednisone.
CONCLUSIONS: The patient presented a severe cutaneous adverse reaction 5 weeks after starting phenytoin, which showed overlap according to the scales. Secondary to the ambiguities among SCARs, confirmed cases of overlap are rare. In the acute stage of the disease, early identification of SCARs can be difficult due to overlapping features.
CASE REPORT: A 53-year-old female was diagnosed with diabetes and was being treated with metformin and linagliptin, and with high blood pressure with nifedipine. Secondary to an isolated seizure, she was treated with phenytoin, 5 weeks later, she presented with erythema in the chest region accompanied by pruritus that spread to the abdomen. Treatment was initiated with antihistamines, with poor improvement, progressing to generalized erythema and fever. Upon admission, she presented with generalized polymorphic skin lesions of a maculopapular rash and bullous lesions on the forearms, as well as pustular lesions on the face. Laboratory findings: Leukocytosis with neutrophilia (67%), eosinophilia =3,880/mm3, and acute kidney injury. Biopsy: Chronic interface dermatitis, superficial perivasculitis, and eosinophilia. According to RegiSCAR scoring system with 4 points and the EuroSCAR score with 6 points, both considered probable The patient began steroid therapy with methylprednisolone at 1.5 mg/kg for 3 days, followed by reduced doses of prednisone.
CONCLUSIONS: The patient presented a severe cutaneous adverse reaction 5 weeks after starting phenytoin, which showed overlap according to the scales. Secondary to the ambiguities among SCARs, confirmed cases of overlap are rare. In the acute stage of the disease, early identification of SCARs can be difficult due to overlapping features.